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Abstract 
Background: Patients with an at-risk mental state (ARMS) for psychosis and patients 
with attention-deficit/hyperactivity disorder (ADHD) have many overlapping signs and 
symptoms and hence can be difficult to differentiate clinically. The aim of this study was 
to investigate whether the differential diagnosis between ARMS and adult ADHD could 
be improved by neuropsychological testing.  
Methods: 168 ARMS patients, 123 adult ADHD patients and 109 healthy controls (HC) 
were recruited via specialized clinics of the University of Basel Psychiatric Hospital. 
Sustained attention and impulsivity were tested with the Continuous Performance Test, 
verbal learning and memory with the California Verbal Learning Test, and problem 
solving abilities with the Tower of Hanoi Task. Group differences in neuropsychological 
performance were analyzed using generalized linear models. Furthermore, to investigate 
whether adult ADHD and ARMS can be correctly classified based on the pattern of 
cognitive deficits, machine learning (i.e. random forests) was applied.  
Results: Compared to HC, both patient groups showed deficits in attention and 
impulsivity and verbal learning and memory. However, in adult ADHD patients the 
deficits were comparatively larger. Accordingly, a machine learning model predicted 
group membership based on the individual neurocognitive performance profile with good 
accuracy (AUC=0.82). 
Conclusions: Our results are in line with current meta-analyses reporting that 
impairments in the domains of attention and verbal learning are of medium effect size in 
adult ADHD and of small effect size in ARMS patients and suggest that measures of 
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these domains can be exploited to improve the differential diagnosis between adult 
ADHD and ARMS patients. 
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1 Introduction 
Young adults seeking help at psychiatric services frequently suffer from adult attention-
deficit/hyperactivity disorder (ADHD) or an at-risk mental state (ARMS) for psychosis. 
Although the latter is not yet accepted as an official diagnosis, it is increasingly identified 
and treated in clinical practice for the following reasons. First, it is now well established 
that patients who meet ARMS criteria not only have a largely increased risk of 
developing psychosis, but also suffer from psychopathological symptoms and impaired 
psychosocial functioning requiring clinical attention [1]. Second, although comorbidity 
with other psychiatric disorders, particularly with affective and anxiety disorders, is 
high[2], the specific psychopathology of ARMS patients is not adequately addressed by 
existing diagnostic categories [3, 4]. Consequently, the European Psychiatric Association 
(EPA) has recently issued evidence based recommendations for the early detection [5] 
and treatment [6] of these patients. Furthermore, attenuated psychosis syndrome, which 
was defined according to the most frequent ARMS criterion, has been placed in Section 
3 of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) [7] as 
a new disorder for further study. 
The distinction between adult ADHD and ARMS for psychosis can be a challenging task 
for clinicians because these disorders have many overlapping signs and symptoms, such 
as difficulties concentrating, lack of attention and other cognitive deficits [8, 9], 
disorganized behavior, performance problems in school or at work, and problems with 
relationships [10, 11]. Additionally, both disorders can present with restlessness, 
nervousness, irritability, hypersensitivity, sudden lack of interest, initiative, energy and 
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drive, low frustration tolerance, as well as poor resilience to stress [12, 13]. Furthermore, 
both disorders frequently occur in early adulthood and both are considered 
neurodevelopmental in origin [14, 15]. Moreover, ADHD in childhood has been found to 
be associated with an increased risk of schizophrenia in adulthood both in prospective 
follow-up [16, 17] and retrospective studies [18, 19]. Likewise, individuals genetically at-
risk for schizophrenia [20, 21] and patients with psychosis [22] have been found to more 
frequently demonstrate ADHD-like features than healthy controls. It has been suggested 
that the overlap between ADHD and psychotic disorders is due to shared genetic [23] 
and environmental risk factors, particularly obstetric complications [24]. Another potential 
explanation is that – due to their similar clinical manifestation – ADHD is a frequent 
misdiagnosis of early signs of psychotic disorders [17]. 
Missclassifying patients with an ARMS for psychosis as ADHD patients can lead to 
inappropriate and even potentially harmful treatment of these patients. Specifically, since 
ADHD is most commonly treated with stimulant drugs which exert their pharmacological 
effects via increasing the levels of dopamine [25], and since increased levels of synaptic 
dopamine are implicated in the generation of psychotic symptoms [26], treating ARMS 
patients as ADHD patients could potentially exacerbate (pre-)psychotic symptoms in 
these patients [for review, see 27].  
A possible way to improve differential diagnosis between these two disorders is to take 
the neuropsychological performance profile into account. Although current meta-
analyses indicate that – compared to healthy controls (HC) – both adult ADHD and 
ARMS for psychosis patients show impairments across a wide range of cognitive 
domains, the degree and pattern of impairments seem to differ. While adult ADHD 
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patients were found to be most strongly impaired in sustained and selective attention, 
inhibition, and verbal learning and memory with effect sizes in the small to medium range 
[9, 28, 29]. ARMS patients showed the largest impairments in speed of processing, 
social cognition and verbal learning with, however, mostly small effect sizes [8]. 
However, to our knowledge, no study has directly tested cognitive performance 
differences between adult ADHD and ARMS patients. Furthermore, it is currently 
unknown whether potential differences on the group level could be exploited to facilitate 
diagnostic classification on the individual level by means of automated pattern 
recognition or machine learning methods. This is unfortunate because 
neuropsychological testing is already routinely conducted in early detection services for 
both disorders and has shown promise in the classification between ADHD and various 
other psychiatric disorders, including mood and anxiety disorders [30-33], autism 
spectrum disorders [34], and borderline personality disorders [35], and between ARMS 
for psychosis and depressive disorders [36]. 
Thus, the aim of this study was 1) to directly test neuropsychological performance 
differences between adult ADHD, ARMS for psychosis patients, and HC in the domains 
of sustained attention and impulsivity, verbal learning and memory, and problem solving 
abilities and 2) to estimate the classification accuracy of machine learning model 
predicting group membership from all neurocognitive performance measures combined. 
Based on the above mentioned meta-analyses [8, 9, 28, 29], we hypothesized that both 
patient groups would show worse cognitive performance in all tested domains relative to 
healthy controls and that adult ADHD patients would show larger deficits than ARMS 
patients in the domains of attention and impulsivity and verbal learning and memory, but 
   
 
 7 
 
 
not problem solving abilities. Furthermore, we expected that classification between adult 
ADHD and ARMS patients based on all neuropsychological performance measures 
combined can be achieved with moderate to high accuracy.  
2 Methods 
2.1 Study design 
In this cross-sectional study, the cognitive performance of three groups was compared: 
1) patients with adult ADHD, 2) patients with an ARMS, and 3) healthy controls (HC). All 
participants provided their written informed consent. The study was approved by the by 
the local ethics committee (Ethikkommission der Nordwest‐ und Zentralschweiz) and 
conformed to the Declaration of Helsinki. 
2.2 Recruitment of patients with adult ADHD 
Patients with adult ADHD were recruited via the ADHD Special Consultations Unit of the 
Outpatient Department of the University of Basel Psychiatric Hospital between 2010 and 
2014. All referrals to this Unit underwent an extensive ADHD screening procedure 
conducted by two independent experts and including a clinical interview, a self-rating and 
an observer-rating scale. School certificates and/or reports from teachers on behavioral 
problems were also considered. The procedure conformed to general standards for 
clinical diagnostics and followed the recommendations for the diagnostics and 
management of ADHD.[37] The diagnosis was not made solely on the basis of rating 
scales, but it also took into account a full developmental and psychiatric history. 
Instruments applied in the diagnostic process were the Wender-Reimherr Adult Attention 
Deficit Disorder Rating Scale (WRAADDS) [38] (German version: [39, 40]) and the 
Conners’ Adult ADHD Rating Scales (CAARS) [41]. Former symptoms in childhood were 
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assessed systematically with the short version of the Wender Utah Rating Scale (WURS-
k) [42] (German version: [43]). To check for current symptoms, a combination of the 
results from the clinical interview and the rating scales was used. An ADHD diagnosis 
was given when an individual met at least six criteria of the dimension of inattention 
and/or six criteria of the dimension of hyperactivity/impulsivity according to DSM-IV. Only 
patients who met the diagnostic criteria for ADHD and who were at least 18 years old 
were included into this study. Exclusion criteria were an intelligence quotient (IQ) < 85, 
schizophrenia or other psychotic disorders, a current or most recent episode of a manic 
disorder or current severe major depressive disorder, acute stress disorder, or substance 
intoxication or withdrawal.  
2.3 Recruitment of patients with an ARMS for psychosis 
ARMS patients were recruited and assessed between March 1, 2000 and December 31, 
2016 as part of the Basel Früherkennung von Psychosen (FePsy) study, a prospective 
multilevel study, which aims to improve the early detection of psychosis. A detailed 
description of the study design can be found elsewhere [44, 45]. In brief, individuals 
suspected to be in their early (prodromal) phase of psychosis were referred to our 
specialized early detection clinic at the Outpatient Department of the Psychiatric 
University Hospital Basel, Switzerland. All referrals to the clinic during the study period 
were screened with the Basel Screening Instrument for Psychosis (BSIP) [46], which has 
been specifically designed to identify patients with an ARMS for psychosis or first 
episode of psychosis (FEP). Individuals were classified as being in an ARMS if they met 
one of the following risk criteria: (a) attenuated psychotic symptoms (APS) or brief limited 
intermittent psychotic symptoms (BLIPS) according to the PACE criteria [47], (b) familial 
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aggregation of psychotic disorders in combination with at least two further risk factors 
similar to the PACE criteria, or (c) a minimal amount and combination of certain risk 
factors according to the BSIP [for details, see 46]. The BSIP has been shown to have a 
good interrater reliability (κ= 0.67) for the assessment of the ARMS and a high predictive 
validity [46]. Exclusion criteria were: age < 18 years, insufficient knowledge of German, 
IQ below 85, previous episode of schizophrenic psychosis, psychosis clearly due to 
organic reasons or substance abuse, or psychotic symptomatology within a clearly 
diagnosed affective psychosis or borderline personality disorder. Patients who were 
treated with antipsychotics > 3 weeks or who had exceeded a 2500 mg cumulative 
chlorpromazine equivalent dose were also excluded. 
2.4 Recruitment of healthy controls (HC) 
HC were also recruited and assessed as part of the FePsy study. They were recruited 
from trade schools, hospital staff and through advertisements. Subjects were excluded if 
they had a current or former psychiatric disorder or neurological disease, serious medical 
condition, substance abuse, or a family history of psychiatric disorder. 
2.5 Neuropsychological assessment 
Patients with adult ADHD were assessed at the ADHD Special Consultations Unit and 
patients with an ARMS for psychosis and HC were assessed at the early detection of 
psychosis clinic with neuropsychological test batteries that were overlapping in the 
following tests: 1) Continuous Performance Test (CPT) [48], 2) California Verbal 
Learning Test (CVLT) [49] and 3) the computer administered Tower of Hanoi (ToH) [50]. 
A detailed description of these tests is provided in the online supplementary material. 
2.6 Statistical analysis 
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All data were analyzed using the R language and environment for statistical computing 
[51]. For testing differences between adult ADHD, ARMS and HC groups on 
sociodemographic variables, Pearson’s χ2-tests and analysis of variance (ANOVA) were 
used for categorical and continuous variables, respectively. 
Group differences in neuropsychological performance measures were analyzed using 
generalized linear models (GLM). GLMs are flexible generalizations of the ordinary linear 
regression, which differ from them in two major aspects: First, the distribution of the 
response variable can be non-normal and/or non-continuous (e.g., it can be binary, 
ordered categorical, a count etc.). Second, the dependent variable values are predicted 
from a linear combination of predictor variables, which are connected to the dependent 
variable via a link function (e.g. logit, log, inverse etc.). Thus, GLMs can take advantage 
of the specific structure of each variable and respect natural boundaries and distributions 
of variables when making predictions [for applied examples of GLMs with 
neuropsychological data, see 52, 53]. 
For the number of omissions and commissions in the CPT, we used negative binomial 
models with log-link function because these are count variables (i.e. only non-negative 
integer values are possible). We used negative binomial instead of standard Poisson 
regression for these measures because it allowed handling overdispersion [54]. For 
CVLT performance measures, we used binomial models with logit link function, because 
each measure quantified the number of words that were remembered from one or 
several lists of words with fixed length. For the reaction time in the CPT and the number 
of moves and time to complete in the ToH, Gamma regression models with an inverse 
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link function were a natural choice because these variables were non-negative and right-
skewed. 
To control for confounding effects, all GLMs included sex and age as covariates. We first 
tested for overall group differences using likelihood ratio tests and then performed all 
possible pairwise comparisons using the ghlt function in the R multcomp package [55]. 
P-values were adjusted for multiple testing using the Benjamini-Hochberg procedure [56] 
both across all pairwise group comparisons and neurocognitive variables. 
To find out whether all neurocognitive performance measures combined can successfully 
discriminate between ARMS and ADHD patients on an individual level, we additionally 
analyzed our data with a supervised machine learning method. Specifically, a random 
forest model was trained and tested that predicted group membership based on the 
individual performance across all neurocognitive variables. We chose the random forest 
algorithm because it can automatically 1) accommodate non-linear relationships between 
predictor and outcome variables, 2) capture complex interactions between predictors and 
3) deal with highly correlated predictors, outliers and missing data [57]. Furthermore, it 
has been shown to achieve excellent predictive accuracy over a wide of range predictive 
tasks even without hyperparameter tuning [58]. To eliminate the influence of age and 
sex, we first created two equally sized samples of ADHD and ARMS patients that were 
matched on age and sex using propensity score matching as implemented in the 
matching package for R.[59] Next, a random forest model for binary outcomes was 
trained and tested using 10-fold cross validation with 10 repetitions. The discriminative 
ability of the model was assessed with the cross-validated area under the receiver 
operating characteristic curve (AUC), as well as sensitivity and specificity. Model fitting 
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and performance evaluation was conducted with the R packages randomForest [60] and 
mlr [61], respectively. We additionally assessed the predictive importance of each 
variable by looking at how much the accuracy decreased when the variable was 
randomly permuted using the importance function in package randomForest [60]. 
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3 Results 
3.1 Sample description 
During the above described study periods, 123 adult ADHD patients, 168 ARMS 
patients, and 109 HC fulfilled inclusion criteria and had completed at least one of the 
above described neuropsychological tests. Eleven HC and 23 ARMS patients had to be 
excluded from the current study due to completely missing neuropsychological 
assessment. The excluded patients did not differ from the included patients with regard 
to sociodemographic characteristics. The ADHD, ARMS and HC groups did not differ 
with regard to gender ratios. However, adult ADHD patients were significantly older than 
ARMS patients and HC (see Table 1 for socio-demographic sample characteristics). 
3.2 Group differences in neuropsychological performance 
Standardized mean differences in neuropsychological performance from HC for the 
ARMS and ADHD groups are displayed in Figure 1. Means and SDs, as well as p-values 
for tests of overall and pairwise group differences are provided in Table 2. 
When adjusted for the influence age and sex and corrected for multiple comparisons, 
there were overall group differences in all tested neuropsychological variables, except for 
the number of moves in the 5 disc ToH. Pairwise group comparisons revealed that 
ADHD patients showed a significantly worse performance than HC in all CPT and CVLT 
measures, but not in any ToH measure. ARMS patients also performed worse than HC in 
all performance scores, except for List 1, Trial 1 recall and Long Delay False Alarms in 
the CVLT and number of moves in the 5 disc ToH. Finally, ADHD patients performed 
significantly worse than ARMS patients in all measures except the two ToH measures. 
Repeating the analyses without covariate adjustment did not change results except that 
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ARMS patients additionally showed a significantly worse performance than HC in List 1, 
Trial 1 recall of the CVLT (p = 0.049). As can be seen in Figure 1, cognitive impairments 
were mostly of medium effect sizes in adult ADHD patients and of small effect sizes in 
ARMS patients (see Figure 1). 
3.3 Discrimination between ARMS and ADHD patients using machine learning 
The propensity score matching procedure selected two subgroups of ADHD and ARMS 
each consisting of 101 participants. The two subgroups were no longer significantly 
different with regard to age (ADHD: 29.0 ± 8.2 years, ARMS: 28.3 ± 7.9 years) and sex 
(ADHD: 34.7% Women; ARMS: 34.7% Women). The random forest algorithm was able 
to discriminate the two matched groups with relatively high accuracy based on all 
neurocognitive variables combined (cross-validated AUC = 0.82, balanced accuracy = 
0.75, sensitivity = 0.73, and specificity = 0.77). The variable importance assessment 
revealed that CVLT long delay free recall, CPT reaction time, and CVLT recognition hits 
were the most important predictor variables for discriminating ADHD from ARMS patients 
(see Figure 2). 
4 Discussion 
To our knowledge, this is the first study aiming to discriminate adult ADHD from ARMS 
for psychosis patients based on neuropsychological performance. In line with our 
hypotheses, we could demonstrate that both patient groups show significantly worse 
cognitive performance than HC in the domains of sustained attention and impulsivity and 
verbal learning and memory and that adult ADHD patients show larger deficits in these 
domains than ARMS patients. Accordingly, we could demonstrate that a machine 
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learning algorithm (i.e. random forest) can predict group membership (ADHD vs. ARMS) 
with relatively high accuracy solely based on the individual pattern of cognitive deficits. 
Our findings of small to medium sized cognitive deficits in adult ADHD patients are 
largely consistent with the most recent meta-analyses on cognitive deficits in adult ADHD 
patients [9, 28, 29]. Furthermore, our results confirmed that deficits of attention in general 
and sustained attention in particular, as measured by the CPT, represent one of the core 
features of ADHD. However, in contrast to the most recent meta-analysis of the CPT,[28] 
which reported the strongest effect sizes for the number of omissions and commissions 
and no statistically significant impairment with regard to reaction times, we observed 
significant impairments in all performance scores of the CPT, with reaction time being the 
most strongly impaired. This difference might be explained by the fact that the most 
commonly used CPT version, the Conner’s CPT [41], has 90% target trials with 
responses required for any letter except “X”, whereas the CPT version used in this study 
has only 25% target trials with responses required whenever an “O” is followed by an “X”. 
Our results also support a recent meta-analysis on memory performance in adult ADHD 
patients, which found that these patients show moderate impairments in verbal learning 
and memory resulting from deficits in memory acquisition, but not retrieval problems [29]. 
The cognitive performance deficits that we found in our sample of ARMS patients are 
also largely consistent with those reported in recent meta-analyses [8, 62], which have 
detected impairments of mostly small effects sizes in the domains of sustained attention, 
verbal learning and memory and executive functions. 
In accordance with our hypothesis and reported effect sizes of meta-analyses on adult 
ADHD [9, 28, 29] and ARMS patients [8, 62], we could demonstrate that adult ADHD 
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patients are significantly more impaired than ARMS patients in the domains sustained 
attention and impulsivity and verbal learning and memory, but not in problem solving 
abilities. Furthermore, we could show that these differences on the group level can be 
exploited to make meaningful prediction on the individual level. Specifically, by applying 
a machine learning algorithm to all neurocognitive variables combined we were able to 
discriminate ADHD from ARMS patients with a cross-validated sensitivity of 0.73 and 
specificity of 0.77. Thus, our results clearly support the notion that neuropsychological 
testing could facilitate the differential diagnosis between these two disorders. However, it 
should be noted that our results do not indicate that the pattern of cognitive deficits alone 
could predict the correct diagnosis with sufficient certainty, only that it could provide 
important hints when combined with other signs and symptoms. 
4.1 Strengths and limitations 
A limitation of this study is that adult ADHD and ARMS patients were recruited from two 
different psychiatric services, albeit in the same psychiatric university hospital and across 
a similar time period. Thus, differences in neuropsychological performance could only be 
tested in the three cognitive tasks that were overlapping across the two services. 
Consequently, other important cognitive domains, such as figural memory, verbal 
fluency, speed of processing, and social cognition could not be investigated. Another 
limitation is that ADHD patients were not assessed with the BSIP for being in an ARMS 
for psychosis. Hence, we cannot rule out the possibility that at least some patients would 
fulfill criteria for both disorders. Lastly, the generalization of our results is limited by the 
fact that women and patients diagnosed with the inattentive subtype of ADHD were 
underrepresented in our sample of adult ADHD patients.  
   
 
 17 
 
 
Strengths of our study are the relatively large sample sizes and the fact that relatively 
few patients in both patient groups were treated with medication (see Table 1). Thus, 
only few ADHD patients were treated with methylphenidate, which has been shown to 
improve performance in the CPT and other cognitive tasks in adult ADHD patients [63]. 
Likewise, only few ARMS and adult ADHD patients were treated with antipsychotics, 
which have been shown to negatively affect cognition, particularly speed of processing 
[64].  
4.2 Conclusions 
The results of this study suggest that neuropsychological testing, particularly of the 
domains of sustained attention and impulsivity and verbal learning and memory, can help 
to improve the differential diagnosis between adult ADHD and ARMS for psychosis. 
Future studies should replicate and extend our findings with larger samples, and more 
comprehensive neuropsychological test batteries. 
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7 Figure Legends 
Figure 1. Standardized mean differences of cognitive performance of ARMS and ADHD 
patients compared to healthy controls. Variables with a minus sign were reversed so that 
higher scores always represent better performance. Differences are adjusted for the 
influence of age and gender. 
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Figure 2. Variable importance for predicting group membership (ARMS vs. ADHD) with 
random forest. 
   
 
 23 
 
 
8 Tables 
Table 1: Socio-demographic sample characteristics 
 HC ARMS ADHD p-value 
 N=109 N=168 N=122  
Age 25.0 (5.28) 25.4 (7.23) 31.6 (9.83) <0.001 
Gender:    0.072 
    Women 47 (43.1%) 50 (29.8%) 45 (36.9%)  
    Men 62 (56.9%) 118 (70.2%) 77 (63.1%)  
Risk group:     
    Prepsychotic only  91 (54.2%)   
    Genetic risk only  16 (9.52%)   
    Mixed prepsychotic + genetic  25 (14.9%)   
    Unspecific only  36 (21.4%)   
Typ:     
    Inattentive type   4 (3.28%)  
    Combined type   118 (96.7%)  
Antidepressants currently  47 (28.0%) 26 (21.3%) 0.249 
Anxiolytics currently  29 (17.3%) 8 (6.56%) 0.012 
Antipsychotics currently  15 (8.93%) 9 (7.38%) 0.797 
Stimulants currently  0 (0.0%) 11 (9.02%) <0.001 
HC = healthy controls; ARMS = at-risk mental state for psychosis; ADHD = attention-deficit/hyperactivity 
disorder 
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Table 2: Cognitive performance of ADHD and ARMS patients 
Variable 
 HC  ARMS  ADHD  
Model 
 p-value 
overall 
 p-value 
ARMS vs. HC 
 p-value 
ADHD vs. HC 
 p-value 
ADHD vs. ARMS  mean SD n  mean SD n  mean SD n      
CPT 
  False alarms  1.1 2.2 108  2.0 3.3 155  3.8 12.3 120  negative binomial  <0.001***   0.013*    <0.001***   0.005**  
  Omissions  0.4 0.8 108  1.1 2.9 155  1.9 4.4 120  negative binomial  <0.001***  <0.001***  <0.001***   0.048*   
  Reaction time  391.3 82.7 108  449.5 133.0 154  531.0 137.4 120  Gamma  <0.001***  <0.001***  <0.001***  <0.001*** 
CVLT 
  Sum of Trials 1-5  62.1 7.7 68  56.9 11.7 142  53.1 10.8 121  binomial  <0.001***  <0.001***  <0.001***  <0.001*** 
  List A, Trial 1  8.2 2.1 68  7.6 2.4 142  7.0 2.3 121  binomial   0.002**    0.087      0.001**    0.040*   
  Short Delay Free Recall  13.8 1.9 68  12.5 2.9 141  11.1 3.0 121  binomial  <0.001***  <0.001***  <0.001***  <0.001*** 
  Short Delay Cued Recall  13.7 2.0 68  13.0 2.6 141  12.0 2.9 120  binomial  <0.001***   0.005**   <0.001***  <0.001*** 
  Long Delay Free Recall  13.9 2.0 61  13.1 3.0 119  11.9 2.7 120  binomial  <0.001***  <0.001***  <0.001***  <0.001*** 
  Long Delay Cued Recall  14.3 1.7 61  13.1 3.0 119  12.2 2.7 120  binomial  <0.001***  <0.001***  <0.001***  <0.001*** 
  List B, Trial 1  8.0 2.2 68  6.7 2.4 141  5.5 2.3 121  binomial  <0.001***  <0.001***  <0.001***  <0.001*** 
  Long Delay False Alarms  0.1 0.3 61  0.3 0.9 117  0.5 1.1 121  binomial  <0.001***   0.059      0.001**    0.022*   
  Long Delay Recognition  15.7 0.5 61  15.5 1.3 117  14.9 1.5 121  binomial  <0.001***   0.024*    <0.001***  <0.001*** 
ToH 
  Time to complete (5 disc)  203.7 141.5 107  261.2 161.3 148  248.6 179.6 102  Gamma   0.011*     0.013*     0.162      0.269    
  Number of moves (5 disc)  52.1 22.3 107  56.1 22.2 149  57.4 22.2 102  Gamma   0.100      0.194      0.121      0.421    
CVLT = California Verbal Learning Task; CPT = Continuous Performance Task; ToH = Tower of Hanoi; HC = Healthy controls; ADHD = Attention-Deficit/Hyperactivity Disorder; ARMS = At-risk mental 
state for psychosis 
All group comparisons are adjusted for the influence of sex and age and corrected for multiple testing using the Benjamini-Hochberg procedure 
* p < 0.05; ** p < 0.01; *** p < 0.001 
 
